News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
845,297 Results
Type
Article (86399)
Company Profile (651)
Press Release (758247)
Multimedia
Podcasts (129)
Webinars (14)
Section
Business (232634)
Career Advice (4127)
Deals (39719)
Drug Delivery (129)
Drug Development (90943)
Employer Resources (198)
FDA (18089)
Job Trends (17332)
News (396338)
Policy (39733)
Tag
Academia (2998)
Academic (1)
Accelerated approval (6)
Adcomms (28)
Allergies (92)
Alliances (56818)
ALS (98)
Alzheimer's disease (1495)
Antibody-drug conjugate (ADC) (153)
Approvals (18059)
Artificial intelligence (299)
Autoimmune disease (27)
Automation (16)
Bankruptcy (405)
Best Places to Work (12616)
BIOSECURE Act (22)
Biosimilars (119)
Biotechnology (448)
Bladder cancer (82)
Brain cancer (30)
Breast cancer (294)
Cancer (2402)
Cardiovascular disease (200)
Career advice (3534)
Career pathing (34)
CAR-T (170)
Cell therapy (476)
Cervical cancer (21)
Clinical research (73340)
Collaboration (900)
Company closure (1)
Compensation (544)
Complete response letters (29)
COVID-19 (2863)
CRISPR (48)
C-suite (260)
Cystic fibrosis (106)
Data (2262)
Decentralized trials (2)
Denatured (45)
Depression (53)
Diabetes (281)
Diagnostics (6905)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (132)
Drug pricing (120)
Drug shortages (31)
Duchenne muscular dystrophy (101)
Earnings (96605)
Editorial (44)
Employer branding (25)
Employer resources (167)
Events (129888)
Executive appointments (759)
FDA (19399)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (796)
Gene editing (119)
Generative AI (26)
Gene therapy (353)
GLP-1 (836)
Government (5151)
Grass and pollen (5)
Guidances (67)
Healthcare (20864)
Huntington's disease (25)
IgA nephropathy (31)
Immunology and inflammation (142)
Indications (30)
Infectious disease (3013)
Inflammatory bowel disease (152)
Inflation Reduction Act (11)
Influenza (54)
Intellectual property (101)
Interviews (812)
IPO (17811)
IRA (48)
Job creations (5187)
Job search strategy (2861)
Kidney cancer (11)
Labor market (42)
Layoffs (555)
Leadership (24)
Legal (10103)
Liver cancer (81)
Lung cancer (342)
Lymphoma (158)
Machine learning (7)
Management (65)
Manufacturing (343)
MASH (75)
Medical device (14609)
Medtech (14614)
Mergers & acquisitions (22433)
Metabolic disorders (765)
Multiple sclerosis (87)
NASH (23)
Neurodegenerative disease (110)
Neuropsychiatric disorders (33)
Neuroscience (2088)
NextGen: Class of 2025 (7667)
Non-profit (5079)
Now hiring (40)
Obesity (411)
Opinion (274)
Ovarian cancer (78)
Pain (97)
Pancreatic cancer (86)
Parkinson's disease (157)
Partnered (23)
Patents (247)
Patient recruitment (116)
Peanut (51)
People (65252)
Pharmaceutical (133)
Pharmacy benefit managers (21)
Phase I (22640)
Phase II (31849)
Phase III (23993)
Pipeline (1244)
Policy (169)
Postmarket research (3551)
Preclinical (10214)
Press Release (72)
Prostate cancer (111)
Psychedelics (38)
Radiopharmaceuticals (267)
Rare diseases (422)
Real estate (7392)
Recruiting (75)
Regulatory (26761)
Reports (57)
Research institute (2653)
Resumes & cover letters (649)
Rett syndrome (5)
RNA editing (5)
RSV (44)
Schizophrenia (80)
Series A (142)
Series B (90)
Service/supplier (27)
Sickle cell disease (58)
Special edition (18)
Spinal muscular atrophy (165)
Sponsored (34)
Startups (4291)
State (2)
Stomach cancer (15)
Supply chain (70)
Tariffs (46)
The Weekly (82)
Vaccines (803)
Venture capitalists (44)
Weight loss (289)
Women's health (40)
Worklife (20)
Date
Last 7 days (933)
Last 30 days (2616)
Last 365 days (34661)
2025 (11349)
2024 (37626)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1270)
Alabama (60)
Alaska (7)
Arizona (268)
Arkansas (14)
Asia (50103)
Australia (8826)
California (6393)
Canada (2054)
China (559)
Colorado (283)
Connecticut (292)
Delaware (156)
Europe (114849)
Florida (935)
Georgia (218)
Hawaii (1)
Idaho (64)
Illinois (607)
India (29)
Indiana (324)
Iowa (12)
Japan (166)
Kansas (111)
Kentucky (26)
Louisiana (13)
Maine (67)
Maryland (962)
Massachusetts (4884)
Michigan (234)
Minnesota (416)
Mississippi (2)
Missouri (85)
Montana (30)
Nebraska (26)
Nevada (65)
New Hampshire (68)
New Jersey (1812)
New Mexico (30)
New York (1810)
North Carolina (1119)
North Dakota (9)
Northern California (2739)
Ohio (216)
Oklahoma (15)
Oregon (46)
Pennsylvania (1416)
Puerto Rico (13)
Rhode Island (35)
South America (1652)
South Carolina (23)
South Dakota (1)
Southern California (2365)
Tennessee (102)
Texas (947)
United States (24466)
Utah (189)
Virginia (160)
Washington D.C. (68)
Washington State (594)
West Virginia (3)
Wisconsin (58)
845,297 Results for "bio path holdings inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bio-Path Holdings Reports Full Year 2024 Financial Results
March 31, 2025
·
7 min read
Press Releases
Bio-Path Holdings Expands Global Patent Portfolio
February 14, 2025
·
4 min read
Press Releases
Bio-Path Holdings Provides Key Clinical Updates
February 14, 2025
·
6 min read
Policy
Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q1 24
Dallas, Texas--(Newsfile Corp. - June 4, 2024) - Bio-Path Holdings, Inc. (NASDAQ: BPTH): Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (NASDAQ: BPTH) for Q1 2024.
June 4, 2024
·
1 min read
Press Releases
Bio-Path Holdings Achieves Third Pre-Clinical Milestone Confirming Potential of BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients
May 1, 2025
·
5 min read
Press Releases
Bio-Path Holdings Announces Pre-Clinical Results Signaling Increased Potential for BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients
March 18, 2025
·
5 min read
Press Releases
Bio-Path Holdings Provides 2025 Clinical and Operational Update
January 13, 2025
·
9 min read
Business
Bio-Path Holdings Reports First Quarter 2024 Financial Results
Bio-Path Holdings, Inc. announced its financial results for the first quarter ended March 31, 2024 and provided an update on recent corporate developments.
May 15, 2024
·
7 min read
Press Releases
Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q3 24
December 13, 2024
·
1 min read
Drug Development
Bio-Path Holdings to Present Data at 2024 European Hematology Association Congress
Bio-Path Holdings, Inc. announced an upcoming poster presentation at the 2024 European Hematology Association Congress, taking place June 13-16, 2024 in Madrid, Spain.
May 24, 2024
·
4 min read
1 of 84,530
Next
